目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. GLOBAL PEDIATRIC MEDICINE MARKET, BY TYPE
6.1. Overview
6.2. Respiratory Drugs
6.3. Digestive Medicine
6.4. Anti-Infective Drugs
6.5. Nutritional Supplements
6.6. Others

7. GLOBAL PEDIATRIC MEDICINE MARKET, BY APPLICATION
7.1. Overview
7.2. Hospital
7.3. Pharmacy
7.4. Clinic

8. GLOBAL PEDIATRIC MEDICINE MARKET, BY REGION
8.1. Overview
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. UK
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. South Korea
8.3.5. Australia
8.3.6. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Middle East
8.4.2. Africa
8.4.3. Latin America

9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Pediatric Medicine Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Pediatric Medicine Market,
9.7. Key developments and Growth Strategies
9.7.1. New Product Launch/Service Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2022
9.8.2. Major Players R&D Expenditure. 2022

10. COMPANY PROFILES
10.1. Pfizer
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Products Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Novartis
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Products Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. GlaxoSmithKline
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Products Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. JOHNSON & JOHNSON
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Products Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Sanofi
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Products Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. AstraZeneca
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Products Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Merck & Co.
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Products Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Roche
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Products Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Eli Lilly and Company
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Products Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Abbott Laboratories
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Products Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies

11. APPENDIX
11.1. References
11.2. Related Reports

LIST OF TABLES
TABLE 1 GLOBAL PEDIATRIC MEDICINE MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL PEDIATRIC MEDICINE MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 NORTH AMERICA: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 7 US: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 8 US: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 9 CANADA: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 10 CANADA: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 3 GERMANY: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 4 GERMANY: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 FRANCE: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 6 FRANCE: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 7 ITALY: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 8 ITALY: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 9 SPAIN: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 10 SPAIN: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 11 UK: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 12 UK: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 13 REST OF EUROPE: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 14 REST OF EUROPE: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 15 ASIA-PACIFIC: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 16 ASIA-PACIFIC: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 17 JAPAN: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 18 JAPAN: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 19 JAPAN: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 20 CHINA: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 21 INDIA: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 22 INDIA: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 23 AUSTRALIA: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 24 AUSTRALIA: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 25 SOUTH KOREA: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 26 SOUTH KOREA: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 27 REST OF ASIA-PACIFIC: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 28 REST OF ASIA-PACIFIC: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 29 REST OF THE WORLD: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 30 REST OF THE WORLD: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 31 MIDDLE EAST: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 32 MIDDLE EAST: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 33 AFRICA: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 34 AFRICA: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 35 LATIN AMERICA: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 36 LATIN AMERICA: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PEDIATRIC MEDICINE MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PEDIATRIC MEDICINE MARKET
FIGURE 4 GLOBAL PEDIATRIC MEDICINE MARKET, SHARE (%), BY TYPE, 2022
FIGURE 5 GLOBAL PEDIATRIC MEDICINE MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 6 GLOBAL PEDIATRIC MEDICINE MARKET, SHARE (%), BY REGION, 2022
FIGURE 7 NORTH AMERICA: PEDIATRIC MEDICINE MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 EUROPE: PEDIATRIC MEDICINE MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 ASIA-PACIFIC: PEDIATRIC MEDICINE MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 REST OF THE WORLD: PEDIATRIC MEDICINE MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 GLOBAL PEDIATRIC MEDICINE MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 12 PFIZER: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 PFIZER: SWOT ANALYSIS
FIGURE 14 NOVARTIS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 NOVARTIS: SWOT ANALYSIS
FIGURE 16 GLAXOSMITHKLINE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 GLAXOSMITHKLINE: SWOT ANALYSIS
FIGURE 18 JOHNSON & JOHNSON: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 JOHNSON & JOHNSON: SWOT ANALYSIS
FIGURE 20 SANOFI: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 SANOFI: SWOT ANALYSIS
FIGURE 22 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 ASTRAZENECA: SWOT ANALYSIS
FIGURE 24 MERCK & CO.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 MERCK & CO.: SWOT ANALYSIS
FIGURE 26 ROCHE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 ROCHE: SWOT ANALYSIS
FIGURE 28 ELI LILLY AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 ELI LILLY AND COMPANY: SWOT ANALYSIS
FIGURE 30 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 ABBOTT LABORATORIES: SWOT ANALYSIS
Source: https://www.marketresearchfuture.com/reports/pediatric-medicine-market/toc